Daniel D. Pinschewer

Basel, BS, Switzerland

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications

Baseline interferon signaling in monocytes and antibody-mediated innate activation are associated with reactogenicity to mRNA vaccines.

Baseline interferon signaling in monocytes and antibody-mediated innate activation are associated with reactogenicity to mRNA vaccines.

Journal: Science translational medicine
Published: August 26, 2026

Chronic infection perturbs the affinity hierarchy of antiviral B cells.

Chronic infection perturbs the affinity hierarchy of antiviral B cells.

Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: March 31, 2026

Non-cytolytic re-engineering of a viral vaccine vector enables durable effector-memory T cell immunity by reinforcing type I IFN induction.

Non-cytolytic re-engineering of a viral vaccine vector enables durable effector-memory T cell immunity by reinforcing type I IFN induction.

Journal: Molecular therapy. Nucleic acids
Published: November 24, 2025

CD8+ T cell responses recognizing immunodominant Chlamydia antigens fail to protect against infection.

CD8+ T cell responses recognizing immunodominant Chlamydia antigens fail to protect against infection.

Journal: iScience
Published: September 26, 2025

Perinatal infection elicits clonally restricted T follicular helper cell responses that drive antibody-mediated viral control.

Perinatal infection elicits clonally restricted T follicular helper cell responses that drive antibody-mediated viral control.

Journal: Immunity
Published: August 20, 2025

Novel adenovirus vaccine vectors lacking thrombosis-associated interactions with platelet factor 4.

Novel adenovirus vaccine vectors lacking thrombosis-associated interactions with platelet factor 4.

Journal: iScience
Published: June 23, 2025

B cell immunity to the Lassa virus glycoprotein is a correlate of vaccination-induced virus control in mice.

B cell immunity to the Lassa virus glycoprotein is a correlate of vaccination-induced virus control in mice.

Journal: Nature communications
Published: May 28, 2025

Orf virus-based vectors induce potent germinal center B cell, Tfh cell, and CD8+ T cell responses.

Orf virus-based vectors induce potent germinal center B cell, Tfh cell, and CD8+ T cell responses.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 13, 2025

mRNA prime-boost vaccination promotes clonal continuity in germinal center reactions and broadens SARS-CoV-2 variant coverage.

mRNA prime-boost vaccination promotes clonal continuity in germinal center reactions and broadens SARS-CoV-2 variant coverage.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 10, 2025

Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines.

Report of a SPEAC webinar 22 september 2023: Sensorineural hearing loss, lassa virus disease and vaccines.

Journal: Vaccine
Published: September 22, 2024

Oligodendrocyte-derived IL-33 regulates self-reactive CD8+ T cells in CNS autoimmunity.

Oligodendrocyte-derived IL-33 regulates self-reactive CD8+ T cells in CNS autoimmunity.

Journal: The Journal of experimental medicine
Published: July 11, 2024

Durable lymphocyte subset elimination upon a single dose of AAV-delivered depletion antibody dissects immune control of chronic viral infection.

Durable lymphocyte subset elimination upon a single dose of AAV-delivered depletion antibody dissects immune control of chronic viral infection.

Journal: Immunity
Published: June 19, 2024
Showing 1-12 of 69

Last Updated: 09/26/2026